Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Literature
1.
World Health Organization (WHO) (2014) Resolution WHA 67.25. Antimicrobial resistance. In: Sixty-seventh World Health Assembly, Geneva, 24 May 2014. Agenda item 16.5
2.
Centers for Disease Control and Prevention (CDC) (1995) Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 44(RR-12):1–13
3.
Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, Klare I, Kristinsson KG, Leclercq R, Lester CH, Lillie M, Novais C, Olsson-Liljequist B, Peixe LV, Sadowy E, Simonsen GS, Top J, Vuopio-Varkila J, Willems RJ, Witte W, Woodford N (2008) Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 13(47)
4.
High Committee of French Public Health (Haut Conseil de la Santé Publique). Commission spécialisée «Sécurité des patients» (CsSP) (2010) Maîtrise de la diffusion des bactéries commensales multirésistantes aux antibiotiques importées en France lors de la prise en charge de patients rapatriés de l’étranger
5.
Bourdon N, Bérenger R, Lepoultier R, Mouet A, Lesteven C, Borgey F, Fines-Guyon M, Leclercq R, Cattoir V (2010) Rapid detection of vancomycin-resistant enterococci from rectal swabs by the Cepheid Xpert vanA/vanB assay. Diagn Microbiol Infect Dis 67:291–293CrossRefPubMed
6.
Babady NE, Gilhuley K, Cianciminio-Bordelon D, Tang Y-W (2012) Performance characteristics of the Cepheid Xpert vanA assay for rapid identification of patients at high risk for carriage of vancomycin-resistant Enterococci. J Clin Microbiol 50:3659–3663CrossRefPubMedPubMedCentral
Metadata
Title
Use of ESwab in the Xpert® vanA/vanB PCR assay
Authors
S. Rasoanandrasana
J.-W. Decousser
V. Cattoir
B. Berçot
C. Domrane
V. Fihman
A. Grillon
A. Lesenne
L. Raskine
E. Cambau
H. Jacquier
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2818-2

Other articles of this Issue 4/2017

European Journal of Clinical Microbiology & Infectious Diseases 4/2017 Go to the issue

Original Article

The resident microflora of voided midstream urine of healthy controls: standard versus expanded urine culture protocols

Original Article

Epidemiology and reporting of candidaemia in Belgium: a multi-centre study

Original Article

Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China

Original Article

The value of specialist care—infectious disease specialist referrals—why and for whom? A retrospective cohort study in a French tertiary hospital

Review

The slippery difficulty of ever containing drug resistance with current practices

Original Article

Infectious encephalitis: utility of a rational approach to aetiological diagnosis in daily clinical practice
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits